SC

Sam Corcos

Co-founder, CEO at Levels

New York, New York

Invests in

  • Min Investment:

    $5,000.00
  • Max Investment:

    $50,000.00
  • Target Investment:

    $25,000.00

Work Experience

2019

  • Co-Founder, CEO

    2019

    Levels is an a16z-backed health tech company, here to help you see how food affects your health. By leveraging biosensors like continuous glucose monitors (CGM), Levels provides real-time feedback on how diet and lifestyle choices impact your metabolic health. Our Members are using personalized data to discover their optimal diet, control their weight, and reduce long-term health risk.

2016 - 2018

  • Founder, CTO (acquired Feb '20)

    2016 - 2018

    Y Combinator S17. CarDash is an automotive repair concierge service that makes car maintenance as painless as possible. I founded the company along with Yinon and Todd, built the original technology stack, and scaled up the engineering team. Built with a statically-hosted (CloudFront) React frontend using Redux and Apollo for state and data management. Backend built with Node, GraphQL, Apollo, and Serverless. Native app built with React Native, Redux, and Apollo.

2015 - 2017

  • Founder, CTO

    2015 - 2017

    At Sightline Maps, we built a system to 3D printing topographical maps primarily marketed to the US Military. We eventually expanded our functionality to include LiDAR data visualization and VR. Worked with Special Operations Command (SOCOM) to develop mapping technology under a Cooperative Research and Development Agreement (CRADA). Built with a mostly-serverless architecture with a statically-hosted frontend with React and S3/CloudFront, Phoenix and Python/Flask backend, and image processing handled by AWS Lambda.

  • Founder, Engineering Lead

    2013 - 2015

    Worked with a domain expert to built a better estimating software tool for the construction industry. The product focused on countertop fabricators to allow them to send more, accurate bids in a fraction of the time it took with contemporary methodology. Built with Meteor and Blaze.

  • Researcher

    2005 - 2006

    Two-year summer internship in the oncology department under Dr. Paul Gumerlock and Dr. Phil Mack. Co-author of "Sequence-dependent of apoptosis from green tea polyphenol, epigallocatechin-3-gallate (EGCG) plus cisplatin (CDDP) in non-small cell lung carcinoma (NSCLC) cells."